Publications
prescription drugs
November 18th, 2022

prescription drugs
November 18th, 2022
Regence Leads the Industry in Biosimilar Adoption
Greater adoption of biosimilars is one path to driving down drug costs in the United States. Effectively increasing uptake will require collaboration between all segments of the health care system. Regence health plans are leading the industry in biosimilars utilization with 95 percent adoption, thus reducing specialty drug spend by $30 million since 2019.
4 min read
Topics
-
prescription drugsDecember 1st, 2022prescription drugsDecember 1st, 2022
Improving Drug Affordability: The Promise of Biosimilars
Biosimilars were first approved for use in the United States in 2015. With a growing number of available biosimilar products and a need to decrease the costs associated with prescription drugs, are biosimilars on track to deliver the savings promised? What role do payers and providers play in advancing broader adoption of biosimilars as a safe and effective treatment? Read key takeaways from the virtual discussion and view the recording!2 min read -
prescription drugsNovember 18th, 2022prescription drugsNovember 18th, 2022
Regence Leads the Industry in Biosimilar Adoption
Greater adoption of biosimilars is one path to driving down drug costs in the United States. Effectively increasing uptake will require collaboration between all segments of the health care system. Regence health plans are leading the industry in biosimilars utilization with 95 percent adoption, thus reducing specialty drug spend by $30 million since 2019.4 min read -
prescription drugsNovember 10th, 2022prescription drugsNovember 10th, 2022
What’s in the Bag? Revealing hospitals' excessive markups on specialty drugs
With the cost of prescription drugs on the rise, specialty drugs that treat the most severe conditions and illnesses are no exception. We explore the importance of cost control strategies to acquire specialty drugs and how some health care providers are aiming to remove these strategies to increase their revenue margins.8 min read -
October 27th, 2022October 27th, 2022
2022 Oregon State of Reform Health Policy Conference
The RHPC team sponsored and attended the 2022 Oregon State of Reform Health Policy Conference, bringing together stakeholders from across the region to discuss the most important topics facing the state.4 min read -
prescription drugsOctober 26th, 2022prescription drugsOctober 26th, 2022
Drug Manufacturers’ Billion-Dollar Scheme
Copay coupons—the solution for the unreasonable cost of specialty medications or a carefully crafted trojan horse disrupting affordability in our health care system?7 min read -
prescription drugsOctober 12th, 2022prescription drugsOctober 12th, 2022
Oregon Attempts to Address the High Costs of Drugs: Q&A with DCBS Director Andrew Stolfi
In 2018, Oregon passed a law creating the Oregon Prescription Drug Price Transparency program. The program has been able to provide policymakers, consumers and stakeholders across healthcare with information about the one of the most complicated areas in health care- pharmaceuticals. We spoke with Oregon DCBS Director, Andrew Stolfi, to discuss the Prescription Drug Price Transparency Program and the newly created Prescription Drug Affordability Board.6 min read -
prescription drugsOctober 5th, 2022prescription drugsOctober 5th, 2022
Prescription Drug Costs: Striking a Balance Between Innovation and Affordability
We are living in a new “golden age” of prescription drug innovation. Over the last several years, advancements in biologics, as well as the development of cell and gene therapies offer tremendous promise for extending people’s quality of life and even curing debilitating diseases. The downside is that these are among the most expensive drug therapies on the market with more to come.3 min read -
guest articleSeptember 22nd, 2022guest articleSeptember 22nd, 2022
The Inflation Reduction Act of 2022: Historic Transformations in Medicare, Rx Drug Pricing and the Affordable Care Act
How does the Inflation Reduction Act affect Medicare prescription drug prices? In this article, we discuss how the Inflation Reduction Act of 2022 will make historic changes to the Affordable Care Act, Medicare, prescription drug pricing.7 min read -
health policySeptember 20th, 2022health policySeptember 20th, 2022
NASHP 2022: Recapping the 35th Annual National Academy for State Health Policy Conference
Last week, the RHPC team sponsored and attended NASHP's 35th Annual Conference held in Seattle, WA. After the event convened over 750 policymakers across the country, we discuss the three themes that emerged from the conference.3 min read
Subscribe to our newsletter
Our newsletter keeps you informed with all the Regence Health Policy Center's programming, initiatives and community events.